Search for: All records

Abstract Precise modulation of excitable tissues—including neurons and cardiomyocytes—is essential for both understanding physiological functions and developing advanced therapies for neurological and cardiac disorders. Conventional modulation techniques such as electrical stimulation, pharmacological intervention, and optogenetics, face limitations in terms of invasiveness, spatiotemporal resolution, and/or requirement for genetic modulation. Optoelectronic interfaces based on light‐matter interaction have emerged as promising alternatives. These platforms offer wireless, nongenetic modulation capabilities with high spatiotemporal resolution and minimal invasiveness and risks of infection. Here, a summary of recent advances in nongenetic optoelectronic modulation strategies is presented. Aspects such as material selection and processing, device designs, working principles, and fabrication techniques are discussed. Then, key characterization methodologies, including benchtop assessments and validation within the living systems are discussed. Alongside the discussion, representative applications across in vitro and in vivo models of cardiac and central/peripheral nervous systems are highlighted. Finally, future directions and clinical opportunities, aiming to provide a thorough reference for the continued development of this field for both fundamental research and next‐generation therapeutic applications are explored. 

Abstract Glutamate is one of the most important excitatory neurotransmitters within the mammalian central nervous system. The role of glutamate in regulating neural network signaling transmission through both synaptic and extra‐synaptic paths highlights the importance of the real‐time and continuous monitoring of its concentration and dynamics in living organisms. Progresses in multidisciplinary research have promoted the development of electrochemical glutamate sensors through the co‐design of materials, interfaces, electronic devices, and integrated systems. This review summarizes recent works reporting various electrochemical sensor designs and their applicability as miniaturized neural probes to in vivo sensing within biological environments. We start with an overview of the role and physiological significance of glutamate, the metabolic routes, and its presence in various bodily fluids. Next, we discuss the design principles, commonly employed validation models/protocols, and successful demonstrations of multifunctional, compact, and bio‐integrated devices in animal models. The final section provides an outlook on the development of the next generation glutamate sensors for neuroscience and neuroengineering, with the aim of offering practical guidance for future research. 

Liquid transport is an essential functionality in microfluidic operation. This review summarizes emerging strategies for liquid management in bioelectronics, with a focus on system-level integration and applications. 

Biosensors are widely applied in biomarker detection. Their widespread use necessitates regeneration methods to ensure cost-effectiveness and sustainability. This mini-review systematically summarizes recently reported regeneration techniques. 

Human–machine interfaces have received significant attention for their potential in VR/AR. This review summarizes recent progress in simulating physical and chemical sensations for enhancing eating experiences by utilizing wearable electroncis. 

Abstract Chemical biomarkers in the central nervous system can provide valuable quantitative measures to gain insight into the etiology and pathogenesis of neurological diseases. Glutamate, one of the most important excitatory neurotransmitters in the brain, has been found to be upregulated in various neurological disorders, such as traumatic brain injury, Alzheimer's disease, stroke, epilepsy, chronic pain, and migraines. However, quantitatively monitoring glutamate release in situ has been challenging. This work presents a novel class of flexible, miniaturized probes inspired by biofuel cells for monitoring synaptically released glutamate in the nervous system. The resulting sensors, with dimensions as low as 50 by 50 μm, can detect real‐time changes in glutamate within the biologically relevant concentration range. Experiments exploiting the hippocampal circuit in mice models demonstrate the capability of the sensors in monitoring glutamate release via electrical stimulation using acute brain slices. These advances could aid in basic neuroscience studies and translational engineering, as the sensors provide a diagnostic tool for neurological disorders. Additionally, adapting the biofuel cell design to other neurotransmitters can potentially enable the detailed study of the effect of neurotransmitter dysregulation on neuronal cell signaling pathways and revolutionize neuroscience.